Xianzhong Ding, MD, PhD, ABPP

Xianzhong Ding, MD, PhD, ABPP

Pathology

Associate Professor

Languages Spoken

English, Chinese

Clinical Expertise

Biography

Interests

Medical Education

Medical School
Tong Ji Medical University, China
Residency
Northwestern University Feinberg School of Medicine/Northwestern Memorial Hospital - Pathology: Anatomic & Clinical Pathology
Fellowship
  • The Mount Sinai School of Medicine/The Mount Sinai Hospital - Gastrointestinal Pathology

Board Certification

American Board of Pathology, Anatomic Pathology & Clinical Pathology

Research

  • Studies on the Tissue Localization of HKDC1 a Putative Novel Fifth Hexokinase, in Humans, Khan, M. W.; Ding, X.; Cotler, S. J.; Clarke, M.; Layden, B. T., The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
  • Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma Grace, S. A.; Meeks, M. W.; Chen, Y.; Cornwell, M.; Ding, X.; Hou, P.; Rutgers, J. K.; Crawford, S. E.; Lai, J. P., Anticancer Research
  • Drug-Induced Liver Injury in the Setting of Glycogenic Hepatopathy Maharaj, V.; Fitz, M.; Ding, X., Journal of general internal medicine
View All ResearchShow Less
  • Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis Arffa, M. L.; Zapf, M. A.; Kothari, A. N.; Chang, V.; Gupta, G. N.; Ding, X.; Al-Gayyar, M. M.; Syn, W.; Elsherbiny, N. M.; Kuo, P. C.; Mi, Z., PLoS ONE
  • FAK kinase activity is required for the progression of c-Met/beta-catenin-driven HCC Na, S.; Arteaga, M.; Zaidi, A.; Colter, S.; Breslin, P.; Ding, X.; Kuo, P.; Nishimura, M.; Zhang, J.; Qiu, W., Gene expression
  • FAK kinase activity is required for the progression of c-Met/beta-catenin-driven HCC Breslin, P.; Kuo, P.; Ding, X.; Cotler, S.; Nishimura, M.; Zhang, J.; Qiu, W.; Arteaga, M.; Zaidi, A.; Shang, N., Gene expression
  • FAK kinase activity is required for the progression of c-Met/beta-catenin-driven HCC Shang, N.; Arteaga, M.; Zaidi, A.; Colter, S.; Breslin, P.; Ding, X.; Kuo, P.; Nishimura, M.; Zhang, J.; Qiu, W., Gene expression
  • Inhibition of SIRT2 suppresses hepatic fibrosis Arteaga, M.; Shang, N.; Ding, X.; Yong, S.; Cotler, S. J.; Denning, M. F.; Shimamura, T.; Breslin, P.; Luscher, B.; Qiu, W., American journal of physiology.Gastrointestinal and liver physiology
  • De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease Ding, X.; Zhang, C.; Frerich, J. M.; Germanwala, A.; Yang, C.; Lonser, R. R.; Mao, Y.; Zhuang, Z.; Zhang, M., Journal of neurosurgery
  • The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. Lyon, H. N.; Emilsson, V.; Hinney, A.; Heid, I. M.; Lasky-Su, J.; Zhu, X.; Thorleifsson, G.; Gunnarsdottir, S.; Walters, G. B.; Thorsteinsdottir, U.; Kong, A.; Gulcher, J.; Nguyen, T. T.; Scherag, A.; Pfeufer, A.; Meitinger, T.; Brönner, G.; Rief, W.; Soto-Quiros, M. E.; Avila, L.; Klanderman, B.; Raby, B. A.; Silverman, E. K.; Weiss, S. T.; Laird, N.; Ding, X.; Groop, L.; Tuomi, T.; Isomaa, B.; Bengtsson, K.; Butler, J. L.; Fox, C. S.; O'Donnell, C. J.; Vollmert, C.; Celedón, J. C.; Wichmann, H. E.; Hebebrand, J.; Stefansson, K.; Lange, C.; Hirschhorn, J. N., PLoS Genetics